title: Evaluation of quantification of HIV-1 RNA viral load in plasma and dried blood spots by use of the semiautomated Cobas Amplicor assay and the fully automated Cobas Ampliprep/TaqMan assay, version 2.0, in Kisumu, Kenya.
abstract: In Kenya, HIV-1 viral load monitoring is commonly performed with the Cobas Amplicor using plasma specimens. Interest is growing in transitioning to real-time PCR (RT-PCR), such as the Cobas Ampliprep/Cobas TaqMan (CAP/CTM), using dried blood spots (DBS). Before implementation, direct evaluation of the two assays using DBS field specimens is required. This study compares the sensitivity, specificity, negative and positive predictive values (NPV and PPV, respectively), concordance, and agreement between HIV-1 viral load measurements using plasma and DBS specimens obtained from 512 HIV-1-infected pregnant females enrolled in the Kisumu Breastfeeding Study and tested with the Cobas Amplicor and CAP/CTM assays. The sensitivity and NPV of viral load detection in DBS specimens were higher with CAP/CTM (sensitivity, 100%; 95% confidence interval [CI], 99.1 to 100.0%; NPV, 100%; 95% CI, 59.0 to 100.0%) than the Cobas Amplicor (sensitivity, 96.6%; 95% CI, 94.3 to 98.1%; NPV, 58.8%; 95% CI, 40.7 to 75.4%). The PPVs were comparable between both assays when using DBS. The specificity of viral load detection in DBS specimens was lower with CAP/CTM (77.8%; 95% CI, 40.0 to 97.2%) than that of the Cobas Amplicor (95.2%; 95% CI, 76.2 to 99.9%). Good concordance and agreement were observed when paired plasma and DBS specimens were tested with both assays. Lower specificity with the CAP/CTM is likely due to proviral HIV-1 DNA amplification and lower detection limits with RT-PCR. However, the CAP/CTM has better sensitivity and higher throughput than the Cobas Amplicor. These findings suggest that DBS may be a suitable alternative to plasma when using RT-PCR, which could increase access to viral load monitoring in resource-limited settings.
authors: Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
authors: Kenneth N
authors: KN
authors: Ouma
authors: Sridhar V
authors: SV
authors: Basavaraju
authors: Jully A
authors: JA
authors: Okonji
authors: John
authors: J
authors: Williamson
authors: Timothy K
authors: TK
authors: Thomas
authors: Lisa A
authors: LA
authors: Mills
authors: John N
authors: JN
authors: Nkengasong
authors: Clement
authors: C
authors: Zeh
mesh_terms: D057205:Automation, Laboratory; D001769:Blood / Q000821:virology*; D003890:Desiccation; D005260:Female; D015658:HIV Infections / Q000821:virology*; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D007630:Kenya; D011237:Predictive Value of Tests; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000821:virology; D012367:RNA, Viral / Q000097:blood*; D012680:Sensitivity and Specificity; D013048:Specimen Handling / Q000379:methods*; D019562:Viral Load / Q000379:methods*
chemical_list: D012367:RNA, Viral
references: Trop Med Int Health. 2005 Aug;10(8):773-81
references: 16045464
references: PLoS Med. 2011 Mar;8(3):e1001015
references: 21468300
references: J Clin Microbiol. 2010 Sep;48(9):3158-64
references: 20660209
references: Antimicrob Agents Chemother. 2009 Mar;53(3):1170-6
references: 19114673
references: HIV Clin Trials. 2008 Jul-Aug;9(4):283-6
references: 18753122
references: N Engl J Med. 2011 Aug 11;365(6):493-505
references: 21767103
references: J Clin Microbiol. 2000 Nov;38(11):4034-41
references: 11060065
references: J Clin Virol. 2010 Jan;47(1):4-7
references: 19962936
references: J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):364-5
references: 19553776
references: AIDS Care. 2008 Mar;20(3):304-10
references: 18351477
references: J Clin Microbiol. 2005 Jun;43(6):2709-17
references: 15956387
references: J Clin Microbiol. 2010 Aug;48(8):2786-92
references: 20519484
references: J Natl Med Assoc. 2006 May;98(5):722-6
references: 16749647
references: J Clin Microbiol. 2008 Dec;46(12):3941-5
references: 18923017
references: J Antimicrob Chemother. 2009 Dec;64(6):1126-9
references: 19776036
references: J Clin Microbiol. 2009 Apr;47(4):1107-18
references: 19193835
references: J Virol Methods. 2009 Feb;155(2):109-17
references: 18952125
references: PLoS Med. 2011 Mar;8(3):e1000430
references: 21468304
references: J Clin Virol. 2007 Apr;38(4):304-12
references: 17329164
references: J Clin Microbiol. 1998 Jan;36(1):258-60
references: 9431960
references: PLoS One. 2010 Nov 24;5(11):e14098
references: 21124842
references: J Virol Methods. 2009 Oct;161(1):177-80
references: 19523984
references: Clin Chem Lab Med. 2011 Aug;49(8):1283-8
references: 21619477
references: Clin Infect Dis. 2011 Dec;53(12):1283-90
references: 22080121
references: Eur Infect Dis. 2009;3(1):41-43
references: 21243116
references: J Virol Methods. 2006 Feb;131(2):168-74
references: 16194575
references: J Clin Microbiol. 2010 Apr;48(4):1195-200
references: 20164281
references: J Clin Microbiol. 2010 Aug;48(8):2852-8
references: 20573864
references: Clin Infect Dis. 2009 Sep 15;49(6):976-81
references: 19663598
references: Bioanalysis. 2010 Nov;2(11):1893-908
references: 21083497
references: J Acquir Immune Defic Syndr. 2009 May 1;51(1):3-6
references: 19247185
references: J Clin Virol. 2011 Dec;52 Suppl 1:S83-9
references: 21995930
references: J Int AIDS Soc. 2010 Mar 21;13:11
references: 20302672
references: J Virol Methods. 2005 Sep;128(1-2):128-34
references: 15913797
references: J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):292-5
references: 21317587
references: Trop Med Int Health. 2009 Aug;14(8):856-61
references: 19552661